AI-designed “intrabodies” could unlock new treatments for Alzheimer’s, Parkinson’s and MND
Wednesday, August 19, 2026Want headlines delivered to your inbox?
Subscribe to our free daily newsletter.
Researchers have developed a new way to turn ordinary antibodies into tiny disease-fighting molecules that can work inside human cells, potentially opening new paths for treating Alzheimer’s, Parkinson’s, Huntington’s disease, and motor neurone disease. (via Science Daily)
Read the Full StoryThis article will expire in 19 days.
In the News...
View All Recent News
- Researchers followed 400,000 kids for 20 years and found a lasting pre-K advantage
- A common vape flavoring may disrupt early embryo development
- Experimental eye drops help blind mice see again
- Scientists tested 212 plant-based meat alternatives. Every one contained fungal toxins
- Scientists discover a brain “brake” that can shut down chronic pain
- Eating more ultra-processed foods may raise prostate cancer risk by 30%
- Smart nanoparticles light up brain cancer and destroy what surgery misses
- Vitamin C won’t prevent most colds, but it may do one small thing
- Childhood trauma may leave a lasting “scar” inside brain cells
- A missing color in indoor light may help prevent myopia
- What you eat before age 2 may affect your health 70 years later
- Turmeric compound may protect blood vessels from diabetes damage
- Scientists may have found a shortcut to calorie restriction’s anti-aging benefits
- Your genes may decide whether a low-carb diet sends cholesterol soaring
- Your brain may not actually “make” decisions
- People who live past 110 have an unusual abundance of killer immune cells
- Shingles vaccine linked to 24% lower dementia risk
- Depression may shut down the brain’s ability to make new neurons
- Supercharged “natural killer” cells could be a powerful new cancer weapon
- Gut bacteria may unlock a hidden benefit of vegetables